The Hidden Danger of Potassium Imbalances

For those living with chronic kidney disease or at risk of heart failure, potassium imbalances can pose a serious threat, even becoming life-threatening. While glucose monitoring has seen significant advancements thanks to wearable technology, the realm of potassium monitoring has lagged behind—until now.

Enter Proton Intelligence: A New Frontier in Health Monitoring

Proton Intelligence, a promising startup from Canada, is stepping up to fill this critical gap. They’ve recently secured a $6.95 million seed round led by SOSV and are in the process of developing a cutting-edge continuous potassium monitoring device. With clinical trials in progress, they aim to launch this innovative product by 2025.

How It Works: The Technology Behind the Solution

• A small device is inserted just below the skin to continuously monitor potassium levels.
• A smartphone app syncs with the device, offering real-time updates and alerts if potassium levels deviate from the safe range.
• A clinician dashboard provides comprehensive insights into a patient’s potassium trends for more precise treatment adjustments.

“These highlighted the devastating consequences of ‘flying blind’ when managing potassium levels, because delays in monitoring often lead to preventable hospitalizations, stopping therapies, or even sudden cardiac death,” shared CEO Sahan Ranamukhaarachchi.

– Proton Intelligence

The Visionaries Behind the Innovation

The brains behind Proton Intelligence are CEO Sahan Ranamukhaarachchi and CSO Victor Cadarso. Their journey began a decade ago in Switzerland, where they delved into wearable biosensors research. Today, their combined expertise is driving Proton towards transforming how patients manage their potassium levels.

A Growing Need with Global Implications

The problem is widespread—approximately 10% of the global population is affected by chronic kidney disease. Unfortunately, many face preventable complications due to inadequate monitoring tools and treatment access. Proton’s approach promises a scalable solution that could dramatically change this narrative.

Standing Out in a Competitive Landscape

While several other companies like AliveCor and Renalyse are exploring potassium monitoring solutions, Proton’s unique approach aims for greater usability and impact. Their vision is supported by key investors including We Venture Capital and Trampoline Venture Partners.

The Road Ahead: Exciting Prospects for Healthcare Innovation

Proton Intelligence’s innovative technology holds the potential to revolutionize patient care for those at risk of potassium imbalances. As they move toward clinical validation and eventual market launch, the healthcare landscape eagerly anticipates the impact of their groundbreaking work.